Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-07

Clinical Trial Update: Fecal Calprotectin Collection Protocol

View source ↗

Summary

This clinical trial update outlines the fecal calprotectin collection protocol used in a completed trial sponsored by DiaSorin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: DiaSorin Inc. | Conditions: Inflammatory Bowel Diseases, Irritable Bowel Syndrome | Status: COMPLETED